23/03/2018 - 09:43 StockMarketWire
ImmuPharma said top line results from a study of its Lupuzor drug is expected by mid-April after Simbec-Orion, the con...
23/03/2018 - 07:00 RNS
RNS Number: 6822I Immupharma PLC 23 March 2018 23 March 2018 ImmuPharma PLC ("ImmuPharma" or the "Company") Lupuzor Pivotal Phase III Study Update ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company announces that it has been informed by Simbec-Orion, the contract research organisation conducting our Lu...
05/03/2018 - 16:13 RNS
RNS Number: 7432G Immupharma PLC 05 March 2018 5 March 2018 ImmuPharma PLC ("ImmuPharma" or the "Company") AIM Rule 17 Notice ImmuPharma PLC (LSE: IMM) , specialist drug discovery and development company, announces pursuant to Rule 17 of the AIM Rules for Companies ("AIM Rules"), the following director's disclosure under Schedule T...
15/02/2018 - 07:00 RNS
RNS Number: 9140E Immupharma PLC 15 February 2018 15 February 2018 ImmuPharma PLC ("ImmuPharma" or the "Company") London Investor Evening Monday 26 February 2018 @ 6pm ImmuPharma PLC (LSE: IMM) , specialist drug discovery and development company, is pleased to announce that Tim McCarthy, Chairman, will be presenting at an invest...
|14-11-11||Hybridan's Small Cap Wrap||Hybridan|
|30-10-11||Hybridan's Small Cap Wrap||Hybridan|
|21-10-11||Markets: Eurozone hopes bolster FTSE 100 on Friday||Interactive Investor|
|12-05-11||Hybridan's Small Cap Wrap||Hybridan|
|05-04-11||Markets: FTSE 100 left with marginal losses||Interactive Investor|
|23-02-11||Hybridan's Small Cap Wrap||Hybridan|
|07-10-10||Hybridan's Small Cap Wrap||Hybridan|
|01-07-10||Hybridan's Small Cap Wrap||Hybridan|
|27-05-10||Hybridan's Small Cap Wrap||Hybridan|
|20-05-10||Hybridan's Small Cap Wrap - 20-05-10||Hybridan|
|17-10-09||Hybridan's Small Cap Wrap||Hybridan|